Are you over 18 and want to see adult content?
More Annotations
A complete backup of earlswantsyou.com
Are you over 18 and want to see adult content?
A complete backup of upcomingsbirecruitment.in
Are you over 18 and want to see adult content?
A complete backup of coloradopotguide.com
Are you over 18 and want to see adult content?
A complete backup of packagemapping.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of arquiteturaurbanismotodos.org.br
Are you over 18 and want to see adult content?
A complete backup of foundersspace.com
Are you over 18 and want to see adult content?
A complete backup of hardestyfuneralhome.com
Are you over 18 and want to see adult content?
Text
other
QUEST DIAGNOSTICS BEGINS TO PERFORM COVID-19 ANTIBODY SECAUCUS, N.J., April 21, 2020 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples.With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect. REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ULTHERA RECEIVES NEW CLEARANCE FROM THE FDA The Ulthera ® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy ®, which is cleared to lift skin on the brow, neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company VENTANA LAUNCHES FIRST FULLY AUTOMATED IHC TEST TO DETECT Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the industry’s first BRAF V600E immunohistochemistry (IHC) test 1 to detect the BRAF V600E mutation in a variety of tumors. The test is designed to detect the most frequent BRAF mutation, V600E, which has been found to play a key role in a variety of cancers including colorectal cancer ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors. AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, andother
QUEST DIAGNOSTICS BEGINS TO PERFORM COVID-19 ANTIBODY SECAUCUS, N.J., April 21, 2020 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples.With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect. REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ULTHERA RECEIVES NEW CLEARANCE FROM THE FDA The Ulthera ® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy ®, which is cleared to lift skin on the brow, neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company VENTANA LAUNCHES FIRST FULLY AUTOMATED IHC TEST TO DETECT Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the industry’s first BRAF V600E immunohistochemistry (IHC) test 1 to detect the BRAF V600E mutation in a variety of tumors. The test is designed to detect the most frequent BRAF mutation, V600E, which has been found to play a key role in a variety of cancers including colorectal cancer ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors. ARIZONA COVID-19 VACCINE INFORMATION ADHS has created a survey for consideration to receive COVID-19 vaccine when available. This form is intended for employers of Phase 1B essential workers* to attest that they meet the prioritization criteria and request a COVID-19 vaccine allocation for their workforce. In order to be considered for a vaccine allocation duringPhase 1B when
PFIZER AND BIONTECH TO PROVIDE 500 MILLION DOSES OF … U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022; Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility AZBIO LEGISLATIVE WATCH LIST AZBio Legislative Watch List for 2021. As Arizona’s Statewide Bioscience Industry Association, AZBio works with our elected leaders to educate and inform on the key issues that will help to make Arizona a Top-Tier Bioscience State and works across our community to support our members, our industry, our healthcare partners, and patient advocacy organizations. INVEST SOUTHWEST 2020 VENTURE MADNESS FINALISTS Invest Southwest 2020 Venture Madness Finalists Announced. Finalists will compete in a live pitch competition made up of companies representing four industries: Consumer, Technology, SaaS and Medical for a chance to win a $15,000 cash prize. Each company will advance to the live-demo portion of the contest held Feb 20 at the Tempe Centerfor
MEDTRONIC TEMPE CAMPUS Upcoming Events. An inventor’s journey to the Hall of Fame: A conversation about innovation with Frances Ligler May 27, 2021 - Pandemic Promotional Strategies and Measuring Success VENTANA LAUNCHES FIRST FULLY AUTOMATED IHC TEST TO DETECT Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the industry’s first BRAF V600E immunohistochemistry (IHC) test 1 to detect the BRAF V600E mutation in a variety of tumors. The test is designed to detect the most frequent BRAF mutation, V600E, which has been found to play a key role in a variety of cancers including colorectal cancer IN MEMORIAM: WILL GARTNER In Memoriam: Will Gartner. Will Gartner, serial entrepreneur and a long-time friend, advocate, and active member of AZBio, passed on Saturday, August 1 st. He was 78-years young. Will decided to settle in Arizona in 1983 after selling his network of environmental testing laboratories, which he founded in 1973 and were based in Illinois andTexas.
MSDX WELCOMES DAVID MCCALEB TO ITS BOARD OF DIRECTORS MSDx, Inc., announced today that David McCaleb has joined its Board of Directors. With over thirty years of experience in leading pharmaceutical companies and biotech start-ups, his successful track record in commercialization and fundraising will augment the MSDx team. During Mr. McCaleb’s career he played a central role in theestablishment
RENAE MOOMJIAN
Renae was elected to the AZBio Board of Directors in June of 2014 and has been chair of the AZBio Awards Committee since 2014. Renae has earned a reputation as a trusted advisor with many medical device company leaders here in the U.S. as well as in global markets from Europe to Asia. She has over 20 years of experience in creatingstrategies
VENTANA COMPANION DIAGNOSTICS CAP/CLIA LAB LAUNCHES NEW Ventana Companion Diagnostics CAP/CLIA lab launches new Robust Prototype Assays. TUCSON, Ariz., May 21, 2014 — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the launch of three new companion diagnostic robust prototype assays (RPAs) for the detection of biomarkers PSMA, MDM2 and FGFR, offeringbiotech
AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy VENTANA LAUNCHES FIRST FULLY AUTOMATED IHC TEST TO DETECT Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the industry’s first BRAF V600E immunohistochemistry (IHC) test 1 to detect the BRAF V600E mutation in a variety of tumors. The test is designed to detect the most frequent BRAF mutation, V600E, which has been found to play a key role in a variety of cancers including colorectal cancer ULTHERA RECEIVES NEW CLEARANCE FROM THE FDA Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively lift lax tissue on the neck and the submental (underthe chin).
BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect. XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors. AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy VENTANA LAUNCHES FIRST FULLY AUTOMATED IHC TEST TO DETECT Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the industry’s first BRAF V600E immunohistochemistry (IHC) test 1 to detect the BRAF V600E mutation in a variety of tumors. The test is designed to detect the most frequent BRAF mutation, V600E, which has been found to play a key role in a variety of cancers including colorectal cancer ULTHERA RECEIVES NEW CLEARANCE FROM THE FDA Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively lift lax tissue on the neck and the submental (underthe chin).
BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect. XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors. ARIZONA COVID-19 VACCINE INFORMATION SHARE ACCURATE AND UP-TO-DATE INFORMATION. For technical issues with AZDHS’ vaccine portal, call (602) 542–1000 and for any other questions about the vaccine in Arizona, call 1-(844) 542–8201 or visit your county’s website: AZBIO LEGISLATIVE WATCH LIST AZBio Legislative Watch List for 2021. As Arizona’s Statewide Bioscience Industry Association, AZBio works with our elected leaders to educate and inform on the key issues that will help to make Arizona a Top-Tier Bioscience State and works across our community to support our members, our industry, our healthcare partners, and patient advocacy organizations. PFIZER AND BIONTECH TO PROVIDE 500 MILLION DOSES OF … U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022; Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility MEDTRONIC TEMPE CAMPUS Upcoming Events. An inventor’s journey to the Hall of Fame: A conversation about innovation with Frances Ligler May 27, 2021 - Pandemic Promotional Strategies and Measuring Success VENTANA LAUNCHES FIRST FULLY AUTOMATED IHC TEST TO DETECT Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the industry’s first BRAF V600E immunohistochemistry (IHC) test 1 to detect the BRAF V600E mutation in a variety of tumors. The test is designed to detect the most frequent BRAF mutation, V600E, which has been found to play a key role in a variety of cancers including colorectal cancer MSDX WELCOMES DAVID MCCALEB TO ITS BOARD OF DIRECTORS MSDx, Inc., announced today that David McCaleb has joined its Board of Directors. With over thirty years of experience in leading pharmaceutical companies and biotech start-ups, his successful track record in commercialization and fundraising will augment the MSDxteam.
IN MEMORIAM: WILL GARTNER Will Gartner, serial entrepreneur and a long-time friend, advocate, and active member of AZBio, passed on Saturday, August 1 st.He was78-years young.
ROSHAN PILLAI
SAVR- Stroke and Cardiovascular Risk Assessment using Wearable Technology Presented By Roshan Pillai, BASIS Scottsdale Cardiovascular risk is the risk of a person developing cardiovascular diseases, often sudden. Heart disease is the leading cause of death for both men and women. Most of the current warning tools utilize the threshold level wherein, a warning is given when a patient’s INVEST SOUTHWEST 2020 VENTURE MADNESS FINALISTS “Each year Venture Madness showcases some of the best companies in the Southwest,” says Tim Kelley, 2020 chairman of Invest Southwest, Chairman of Canyon Angels, and Chair of Entrepreneurship at Grand Canyon University Collangelo College of Business. VENTANA COMPANION DIAGNOSTICS CAP/CLIA LAB LAUNCHES NEW TUCSON, Ariz., May 21, 2014 — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the launch of three new companion diagnostic robust prototype assays (RPAs) for the detection of biomarkers PSMA, MDM2 and FGFR, offering biotech and pharmaceutical companies more options in exploring novel treatment options for patients with cancer. AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. AZBIO LEGISLATIVE WATCH LIST AZBio Legislative Watch List for 2021. As Arizona’s Statewide Bioscience Industry Association, AZBio works with our elected leaders to educate and inform on the key issues that will help to make Arizona a Top-Tier Bioscience State and works across our community to support our members, our industry, our healthcare partners, and patient advocacy organizations. AZBIO MEMBER DIRECTORY Welcome to the AZBio Member Directory To learn more about a specific AZBio Member, click the logo or company name on their listing. To return to the main directory from a Member Profile, click "Back". REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
PHOENIX BASED PARADIGM AND VIOMICS ACQUIRED BY EXACT On March 3, 2020, Exact Sciences Corp. (NASDAQ: EXAS) announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two privately held companies based in Phoenix.Together, Paradigm and Viomics provide a differentiated late-stage therapy selection test and deep competencies in sequencing and biomarker discovery, extending Exact Sciences’ lab testing and BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy VENTANA FOUNDER, TOM GROGAN, NAMED AZBIO PIONEER For Immediate Release Arizona: August 12, 2013 The Arizona Bioindustry Association (AZBio) today announced that Thomas M. Grogan, M.D., Founder of Ventana and SVP, Medical Affairs of Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, will be honored with the AZBio Pioneer Award for Lifetime Achievement at the 2013 AZBio Awards on October 10, 2013. VENTANA COMPANION DIAGNOSTICS CAP/CLIA LAB LAUNCHES NEW TUCSON, Ariz., May 21, 2014 — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the launch of three new companion diagnostic robust prototype assays (RPAs) for the detection of biomarkers PSMA, MDM2 and FGFR, offering biotech and pharmaceutical companies more options in exploring novel treatment options for patients with cancer. AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. AZBIO LEGISLATIVE WATCH LIST AZBio Legislative Watch List for 2021. As Arizona’s Statewide Bioscience Industry Association, AZBio works with our elected leaders to educate and inform on the key issues that will help to make Arizona a Top-Tier Bioscience State and works across our community to support our members, our industry, our healthcare partners, and patient advocacy organizations. AZBIO MEMBER DIRECTORY Welcome to the AZBio Member Directory To learn more about a specific AZBio Member, click the logo or company name on their listing. To return to the main directory from a Member Profile, click "Back". REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
PHOENIX BASED PARADIGM AND VIOMICS ACQUIRED BY EXACT On March 3, 2020, Exact Sciences Corp. (NASDAQ: EXAS) announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two privately held companies based in Phoenix.Together, Paradigm and Viomics provide a differentiated late-stage therapy selection test and deep competencies in sequencing and biomarker discovery, extending Exact Sciences’ lab testing and BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy VENTANA FOUNDER, TOM GROGAN, NAMED AZBIO PIONEER For Immediate Release Arizona: August 12, 2013 The Arizona Bioindustry Association (AZBio) today announced that Thomas M. Grogan, M.D., Founder of Ventana and SVP, Medical Affairs of Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, will be honored with the AZBio Pioneer Award for Lifetime Achievement at the 2013 AZBio Awards on October 10, 2013. VENTANA COMPANION DIAGNOSTICS CAP/CLIA LAB LAUNCHES NEW TUCSON, Ariz., May 21, 2014 — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the launch of three new companion diagnostic robust prototype assays (RPAs) for the detection of biomarkers PSMA, MDM2 and FGFR, offering biotech and pharmaceutical companies more options in exploring novel treatment options for patients with cancer. PFIZER AND BIONTECH TO PROVIDE 500 MILLION DOSES OF … U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022; Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility FDA GRANTS ACCELERATED APPROVAL FOR ADUHELM™ AS THE FIRST CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid AZBIO MEMBER DIRECTORY Welcome to the AZBio Member Directory To learn more about a specific AZBio Member, click the logo or company name on their listing. To return to the main directory from a Member Profile, click "Back".JOIN AZBIO | AZBIO
The Value of Membership AZBio's mission is to support the needs of Arizona’s growing life science ecosystem. AZBio is the only statewide organization exclusively focused building Arizona’sBioindustry.
AZBIO AWARDS 2021
The 2021 Life Science Fiesta. It's been two years since we were able to come together in-person to celebrate and make connections. Join us in the life Science Fiesta immediately following the AZBio Awards for dinner and networking with our inspiring students in the Student Discovery Zone, Patient Groups in the Patient Advocacy Pavilion, and visit with exhibitors. ARIZONA BIOSCIENCE WEEK 2021 UNMET Arizona 2021. UNMET Arizona 2021 is a venture conference co-hosted by the Arizona Commerce Authority for Series A/B stage startups. Founders attending this event will be able to network with institutional VC investors, along with their peers at fast growing startups around the country; Investors will be able to meet with 50+ Startups, founders will have the chance to pitch 100+ investors BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect.JOBS
AZBio offers the top jobs available in Bio. Search and apply to open positions or post jobs on AZBio now. XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors. BEACON BIOMEDICAL INC. WINS NIH GRANT TO MAKE COLORECTAL Beacon Biomedical, Inc., a privately held company focused on developing patient friendly cancer screening test has been awarded a Small Business Innovation Research (SBIR) Phase I Grant by the National Institutes of Health. Funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the grant aims to develop and validate an easy, accurate and affordable test to AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, andother
AZBIO LEGISLATIVE WATCH LIST AZBio Legislative Watch List for 2021. As Arizona’s Statewide Bioscience Industry Association, AZBio works with our elected leaders to educate and inform on the key issues that will help to make Arizona a Top-Tier Bioscience State and works across our community to support our members, our industry, our healthcare partners, and patient advocacy organizations. QUEST DIAGNOSTICS BEGINS TO PERFORM COVID-19 ANTIBODY SECAUCUS, N.J., April 21, 2020 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples.With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect. BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ULTHERA RECEIVES NEW CLEARANCE FROM THE FDA The Ulthera ® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy ®, which is cleared to lift skin on the brow, neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors. MSDX WELCOMES DAVID MCCALEB TO ITS BOARD OF DIRECTORS MSDx, Inc., announced today that David McCaleb has joined its Board of Directors. With over thirty years of experience in leading pharmaceutical companies and biotech start-ups, his successful track record in commercialization and fundraising will augment the MSDx team. During Mr. McCaleb’s career he played a central role in theestablishment
AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, andother
AZBIO LEGISLATIVE WATCH LIST AZBio Legislative Watch List for 2021. As Arizona’s Statewide Bioscience Industry Association, AZBio works with our elected leaders to educate and inform on the key issues that will help to make Arizona a Top-Tier Bioscience State and works across our community to support our members, our industry, our healthcare partners, and patient advocacy organizations. QUEST DIAGNOSTICS BEGINS TO PERFORM COVID-19 ANTIBODY SECAUCUS, N.J., April 21, 2020 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples.With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect. BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. ULTHERA RECEIVES NEW CLEARANCE FROM THE FDA The Ulthera ® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy ®, which is cleared to lift skin on the brow, neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors. MSDX WELCOMES DAVID MCCALEB TO ITS BOARD OF DIRECTORS MSDx, Inc., announced today that David McCaleb has joined its Board of Directors. With over thirty years of experience in leading pharmaceutical companies and biotech start-ups, his successful track record in commercialization and fundraising will augment the MSDx team. During Mr. McCaleb’s career he played a central role in theestablishment
ARIZONA COVID-19 VACCINE INFORMATION ADHS has created a survey for consideration to receive COVID-19 vaccine when available. This form is intended for employers of Phase 1B essential workers* to attest that they meet the prioritization criteria and request a COVID-19 vaccine allocation for their workforce. In order to be considered for a vaccine allocation duringPhase 1B when
AZBIO LEGISLATIVE WATCH LIST AZBio Legislative Watch List for 2021. As Arizona’s Statewide Bioscience Industry Association, AZBio works with our elected leaders to educate and inform on the key issues that will help to make Arizona a Top-Tier Bioscience State and works across our community to support our members, our industry, our healthcare partners, and patient advocacy organizations.AZBIO AWARDS 2021
The 2021 Life Science Fiesta. It's been two years since we were able to come together in-person to celebrate and make connections. Join us in the life Science Fiesta immediately following the AZBio Awards for dinner and networking with our inspiring students in the Student Discovery Zone, Patient Groups in the Patient Advocacy Pavilion, and visit with exhibitors. FDA GRANTS ACCELERATED APPROVAL FOR ADUHELM™ AS THE FIRST CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid ARIZONA BIOSCIENCE WEEK 2021 The AZBio Awards Ceremony Celebrates Arizona's leading Educators, Innovators and Companies. Join us for an inspirational celebration of the best of Arizona's Bioscience Industry on October 5, 2021 at the Phoenix Convention Center's West Ballroom. Nominations open April 1st and close on June 4, 2021. Tickets are required for the AZBio Awards. AZBIO AWARD NOMINATIONS The AZBio Awards Celebrate Arizona's leading Educators, Innovators and Companies. Nominations for the 2021 AZBio Awards closed on May 31, 2021. Judging Timeline: March 22, 2021 - Nominations for the 2021AZBio Awards open
IVY BRAIN TUMOR CENTER ANNOUNCES INTERIM RESULTS FROM A Results to be presented at 2021 ASCO Annual Meeting demonstrate that Abemaciclib and LY3214996 achieve pharmacologically-relevant concentrations in Gd-non-enhancing GBM tissue • Ongoing study will accrue an additional 25 patients at the Optimal Time Interval (OTI) identified for tissue samplingMASK UP ARIZONA
Now is the time to #MaskUpAZ. As Arizona re-opens, COVID-19 remains the same viral threat that it has been all along. We admittedly have much to learn about the novel coronavirus, but its highly transmissible nature is well–documented. Re-opening means more, and more variations of, people mixing together than before. MEDTRONIC TEMPE CAMPUS Upcoming Events. An inventor’s journey to the Hall of Fame: A conversation about innovation with Frances Ligler May 27, 2021 - Pandemic Promotional Strategies and Measuring Success IN MEMORIAM: WILL GARTNER In Memoriam: Will Gartner. Will Gartner, serial entrepreneur and a long-time friend, advocate, and active member of AZBio, passed on Saturday, August 1 st. He was 78-years young. Will decided to settle in Arizona in 1983 after selling his network of environmental testing laboratories, which he founded in 1973 and were based in Illinois andTexas.
AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, andother
COVID-19: HEALING & HOPE For news on a wide range of health innovations, visit AZBio News.. For news on the industry response in developing and delivering tests, treatments, and vaccines, visit COVID-19 News.. For updates on the global innovation activities of PhRMA Members, visit COVID-19 Global Innovators.. To learn how you can support new health innovations across the spectrum from discovery to development to QUEST DIAGNOSTICS BEGINS TO PERFORM COVID-19 ANTIBODY SECAUCUS, N.J., April 21, 2020 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples.With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
ARIZONA CONGRESSIONAL DELEGATION Arizona Congressional Delegation. Member Name. DC Phone(202) DC FAX (202) Contact Form. Senator Martha McSally (R- AZ) 224-2235. 228-2862. contact@mcsally.senate.gov. ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors.RENAE MOOMJIAN
Renae was elected to the AZBio Board of Directors in June of 2014 and has been chair of the AZBio Awards Committee since 2014. Renae has earned a reputation as a trusted advisor with many medical device company leaders here in the U.S. as well as in global markets from Europe to Asia. She has over 20 years of experience in creatingstrategies
THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy AZBIOMEMBERSNEWSRESOURCESADVOCACYABOUT AZBIOCONTACT A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry. AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, andother
COVID-19: HEALING & HOPE For news on a wide range of health innovations, visit AZBio News.. For news on the industry response in developing and delivering tests, treatments, and vaccines, visit COVID-19 News.. For updates on the global innovation activities of PhRMA Members, visit COVID-19 Global Innovators.. To learn how you can support new health innovations across the spectrum from discovery to development to QUEST DIAGNOSTICS BEGINS TO PERFORM COVID-19 ANTIBODY SECAUCUS, N.J., April 21, 2020 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples.With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as BANNER ALZHEIMER’S INSTITUTE GETS $27.5M NIH GRANT FOR Banner Alzheimer’s Institute (BAI) has received a grant expected to total $27.5 million over five years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to further investigate biological and cognitive changes preceding the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease. REGENESIS BIOMEDICAL INTRODUCES THE NEW PROVANT INFINITY Scottsdale, Arizona based, Regenesis Biomedical, Inc. has launch the new Provant ® Infinity system that is available purchase for home use when prescribed by a health professional. Outcomes with Provant Therapy are documented in journal articles, white papers, and casereports.
ARIZONA CONGRESSIONAL DELEGATION Arizona Congressional Delegation. Member Name. DC Phone(202) DC FAX (202) Contact Form. Senator Martha McSally (R- AZ) 224-2235. 228-2862. contact@mcsally.senate.gov. ARIZONA-BASED BIOTECH STARTUP BIOLAB SCIENCES ANNOUNCES MyOwn Skin TM is a revolutionary approach that uses a patient’s own skin to accelerate healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. By utilizing a small skin sample, this regenerative approach allows the body to heal itself and is less likely to face infection or rejection. XCELLERATE BIOMEDICAL TECHNOLOGIES ANNOUNCES HALF A Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has announced its second round capital raise of $500k for its first line of products, BioXcellerator™ – a medical strength line of formulations sold exclusively through top dermatologists, plastic surgeons, orthopedists and OB/GYN doctors.RENAE MOOMJIAN
Renae was elected to the AZBio Board of Directors in June of 2014 and has been chair of the AZBio Awards Committee since 2014. Renae has earned a reputation as a trusted advisor with many medical device company leaders here in the U.S. as well as in global markets from Europe to Asia. She has over 20 years of experience in creatingstrategies
THERESA W. FOSSUM, D.V.M., M.S., PH.D., DACVS Dr. Fossum is the Vice President of Research and Strategic Initiatives and a Professor of Veterinary Surgery at Midwestern University. Dr. Fossum is responsible for overseeing the development of the Midwestern University Institute for Healthcare Innovation (IHI) including but not limited to clinical trials, new research funding programs and related work that impacts the One Health philosophy ARIZONA COVID-19 VACCINE INFORMATION ADHS has created a survey for consideration to receive COVID-19 vaccine when available. This form is intended for employers of Phase 1B essential workers* to attest that they meet the prioritization criteria and request a COVID-19 vaccine allocation for their workforce. In order to be considered for a vaccine allocation duringPhase 1B when
MEMBERS | AZBIO
AZBio is a community that works together to make our vision a reality. Membership is at the enterprise level and covers every U.S. employee within your organization. Together we will make Arizona a top-tier bioscience state. Our members cover a wide spectrum from global leaders to start ups. AZBio Members are more that just researchers AZBIO AWARDS 2020: CELEBRATING LIFE & SCIENCE Every year, since 2005, hundreds of people have come together as AZBio honors leaders from across the state of Arizona that illustrate the depth, breadth, and expertise of our bioscience industry. FDA GRANTS ACCELERATED APPROVAL FOR ADUHELM™ AS THE FIRST CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid AZBIO AWARD NOMINATIONS Timeline: March 22, 2021 - Nominations for the 2021 AZBio Awards open. May 31, 2021 - Nominations Close. June 2021 - Honorees Notified. October 5, 2021 - AZBio Awards. Click here for video profiles of past Honorees. Click here for a look back at past AZBio Award Winners.MASK UP ARIZONA
Now is the time to #MaskUpAZ. As Arizona re-opens, COVID-19 remains the same viral threat that it has been all along. We admittedly have much to learn about the novel coronavirus, but its highly transmissible nature is well–documented. Re-opening means more, and more variations of, people mixing together than before. THE GENERATE LIFE SCIENCES FAMILY OF COMPANIES GROWS WITH LOS ANGELES, June 2, 2021 /PRNewswire/ — Generate Life Sciences (Generate) today announced that it has acquired the Cell Care international cord blood banking group (Cell Care), which comprises Cell Care in Australia, along with Insception Lifebank and Cells forLife in Canada.*
AZBIO - JOIN US
Join us. To begin a new AZBio Membership Application, start by selecting your membership level and providing your company information for the AZBio online and printed member directories. You will have the opportunity to input your company logo, company description and key contact information. In the final step, you will be asked to completethe
BEACON BIOMEDICAL’S BESCREENED-CRC TEST RECEIVES CPT Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.. Phoenix, AZ. On April 1, 2020, a new Proprietary Laboratory Analysis CPT Reimbursement Code from the American Medical Association (AMA) specifically for Beacon Biomedical’s BeScreened-CRC test went into effect.JOBS
Job Function collapsed. Administrator (Agency/ Organization) Adult Advanced Practice Registered Nurses / Physician Assistants Associate Veterinarian Biology Cardiology Chair Clinical Lab Technologist Coder/medical coder Coding - Inpatient Coding - Outpatient Customer Service Director Education Education - Cardiovascular EmergencyMedicine - PA
Settings
We use cookies to optimize our website and our service. Cookie Policy(US)
- Privacy
statement
Accept
AZBio is committed to building a top-tier life science industry inArizona
* Members
* Why Join AZBio
* Join AZBio
* AZBio Member Application* Support AZBio
* Member Directory
* My Member Profile
* Save with AZBio Purchasing Power * AZBio Career Center* News
* In The Loop
* AZBio.TV
* Arizona Bio News from Business Wire * BIO News from Business Wire* CEO Blog
* Members
* Opportunities
* Events
* Events Calendar
* Get To Know Arizona at BIO 2019 * Arizona Bioscience Week 2020 * 2020 AZBio Special Supplement and Sponsor Opportunities* AZBio Awards 2020
* White Hat Investors 2020 * AZBio Trailblazer Awards and Legislator Appreciation Luncheon* Resources
* AZBio Career Center* Arizona BioMap
* Perkins Coie Office Hours for AZBio * Arizona Wellbeing Commons* Videos
* Resource Library
* Advocacy
* AZBio Legislative Watch List – 2020 * AZBio Public Policy Principles * Find My Legislator * Request to Speak Instructions * Congressional Calendar – 116th Congress * Arizona Congressional Delegation * BIO Advocacy Tool Kit* Committee
* Government Affairs Blog* About AZBio
* AZBio’s Commitment * Arizona Bioindustry Fact Sheet* AZBio History
* AZBio Staff
* AZBio Board of Directors* Privacy Policy
* Contact
* COVID-19: How to Give Back* COVID-19: Testing
* COVID-19: News
* COVID-19: Business Resources * COVID-19: Federal Relief* Member Login
* Menu
*
Click the image to learn more*
Click here to learn about joining AZBio*
Click here to enter the AZBio Career Center*
AZBio Members save with BIO Business Solutions. Click the image tolearn more.
*
Click the image to learn more*
Click the image to learn more*
Visit AZBio.TV for the latest video presentations* 1
* 2
* 3
* 4
* 5
* 6
* 7
* <
* >
FROM DISCOVERY TO DEVELOPMENT TO DELIVERY AZBIO IS COMMITTED TO BUILDING A TOP-TIER LIFE SCIENCE INDUSTRY INARIZONA.
ARIZONA HAS A SIZABLE AND RAPIDLY GROWING BIOSCIENCE INDUSTRY. STATE BIOSCIENCE FIRMS EMPLOYED 25,686 IN 2016 IN 1,310 INDIVIDUAL BUSINESS ESTABLISHMENTS. INDUSTRY EMPLOYMENT HAS GROWN BY 9 PERCENT SINCE 2014, TWICE THE GROWTH RATE OF THE NATION, WITH FOUR OF THE FIVE MAJOR SUBSECTORS ADDING JOBS DURING THE PERIOD. BOTH DRUGS AND PHARMACEUTICALS AND RESEARCH, TESTING AND MEDICAL LABS HAVE EXPERIENCED DOUBLE-DIGIT JOB GROWTH SINCE 2014. ARIZONA INVENTORS HAVE BEEN AWARDED NEARLY 2,000 BIOSCIENCE-RELATED PATENTS SINCE 2014, AMONG THE SECOND QUINTILE OF STATES IN PATENT ACTIVITY. SINCE 2015, NIH AWARDS TO ARIZONA INSTITUTIONS HAVE INCREASED, REACHING $189 MILLION IN FY 2017. (GET THE FACTS)
GET SOCIAL!
IN THE LOOP
AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.Subscribe __
AZBIO MEMBERS ARE MAKING LIFE BETTTER AZBIO MEMBERS DISCOVER, DEVELOP, AND DELIVER LIFE-SAVING AND LIFE-CHANGING INNOVATIONS.PREMIERE SUPPORTERS
*
*
*
*
*
*
LEADERSHIP SUPPORTERS*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
SUSTAINING MEMBERS
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
GET CONNECTED WITH ARIZONA'S BIOINDUSTRY A KEY COMPONENT IN ARIZONA’S LIFE SCIENCE ECOSYSTEM, THE ARIZONA BIOINDUSTRY ASSOCIATION (AZBIO) IS THE ONLY STATEWIDE ORGANIZATION EXCLUSIVELY FOCUSED ON ARIZONA’S BIOSCIENCE INDUSTRY. AZBIO MEMBERSHIP INCLUDES PATIENT ADVOCACY ORGANIZATIONS, LIFE SCIENCE INNOVATORS, EDUCATORS, HEALTHCARE PARTNERS AND LEADING BUSINESS ORGANIZATIONS. AZBIO IS THE STATEWIDE AFFILIATE OF THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) AND WORKS IN PARTNERSHIP WITH ADVAMED, MDMA, AND PHRMA TO ADVANCE INNOVATION AND TO ENSURE THAT THE VALUE DELIVERED FROM LIFE-CHANGING AND LIFE-SAVING INNOVATION BENEFITS PEOPLE IN ARIZONA AND AROUND THE WORLD. SUCCESS STORIES – GOOD NEWS FROM ARIZONA’S BIOINDUSTRY ABBOTT ANNOUNCES EUA APPROVAL OF RAPID MOLECULAR POINT-OF-CARE TESTFOR COVID-19
ABBOTT LAUNCHES MOLECULAR POINT-OF-CARE TEST TO DETECT NOVEL CORONAVIRUS IN AS LITTLE AS FIVE MINUTES – The Abbott ID NOW™ COVID-19 test brings rapid testing to the front lines – Test to run on Abbott’s point-of-care ID NOW platform – a portable instrument that can be deployed where testing is needed most – ID NOW UARIZONA CANCER CENTER JOINS CANCER PREVENTION AND CONTROL RESEARCHNETWORK
The University of Arizona Cancer Center will receive $1.4 million as a collaborating center with the national network of academic, public health and community partners, working together to reduce the burden of cancer, especially among Hispanic cancer survivors. BIO HOSTS TWO-DAY VIRTUAL RESEARCH SUMMIT ON COVID-19 RESPONSE EFFORTS Participants at the virtual summit included invited leaders from 45 biotech and pharmaceutical companies, global experts in virology and immunology, and government officials, including Ambassador Deborah Birx and Dr. Robert Kadlec, who provided great insights with regards to the government’s coronavirus effort. ADDITIONAL WARNINGS ISSUED FOR COVID-19 POSSIBLE TREATMENTS In the last 48-hours, there have been multiple reports warning the public about the medicines being tested as possible treatments for COVID-19. See below: Chloroquine treats malaria: Will it work against coronavirus? The side effects are risky, experts say AZ Couple took chloroquine phosphate – Man died; Woman in ICU Virus Drug Touted byTrump,
POST NAVIGATION
1 2 3
4 5 6
… 657
Next »
EVENTS
* BIO Fly In 2020 - POSTPONED * 03/31/2020 - 04/01/2020*
* DISCOVER BIO5 - OPEN HOUSE AND RECEPTION - POSTPONED* 04/01/2020
* Tucson
* 5th Annual AZ Cord Blood Conference - Virtual Meeting* 04/02/2020
* Phoenix
* Arizona's Bioscience Roadmap Update Luncheon - Flagstaff - CANCELED* 04/14/2020
* Flagstaff
* FDA Webinar - Clinical Laboratory Improvement Amendments (CLIA) Waiver Applications Final Guidances* 04/14/2020
* USA
AZBIO BUILDS RELATIONSHIPS WITH PARTNERS ACROSS THE COUNTRY PARTNER OPPORTUNITIES FOR AZBIO MEMBERS*
*
*
Click the image to learn more* 1
* 2
* 3
* <
* >
Disclaimer
Privacy Statement (US) Privacy Statement (EU)Cookie Policy (EU)
Privacy Statement (UK)Cookie Policy (UK)
Do Not Sell My Personal Information Copyright 2020 | Arizona Bioindustry Association, Inc.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0